Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorGIUGLIANI, Roberto
dc.contributor.authorFAINBOIM, Alejandro
dc.contributor.authorKIM, Chong Ae
dc.contributor.authorHOROVITZ, Dafne Dain Gandelman
dc.contributor.authorSAKATA, Edna Tiemi
dc.contributor.authorDAMIANO, Ana Paula
dc.contributor.authorMAGALHÃES, Tatiana Sá Pacheco Carneiro
dc.contributor.authorVILLAREAL, Martha Solano
dc.identifier.citationJOURNAL OF INBORN ERRORS OF METABOLISM AND SCREENING, v.7, p.e20190004, 2019
dc.description.abstractAbstract Mucopolysaccharidoses (MPS) constitute a heterogeneous group of rare genetic disorders caused by enzymatic deficiencies that lead to the accumulation of glycosaminoglycans (GAGs). Clinical observations suggest a health-related impairment in quality of life in patients with MPS. Professionals with extensive experience in the care of patients with inborn errors of metabolism, such as MPS, held a meeting in April 2017 to discuss and propose recommendations for the evaluation and management of quality of life in MPS patients in Latin America. In the light of this scenario, the present work summarizes the content of the discussions and presents the recommendations produced at the meeting. The panel had suggested the use of the following tools for the assessment of health-related quality of life (HRQoL): Children's Health Assessment Questionnaire (CHAQ) for children and patients unable to express their feelings, Health Assessments Questionnaire (HAQ) and EuroQol 5 Domains (EQ-5D) scales for adult patients. Based on the scores verified in these scales, the panel proposes interventions that aim reducing the impairment of the quality of life in patients with MPS disorders.eng
dc.publisherLatin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT)eng
dc.relation.ispartofJournal of Inborn Errors of Metabolism and Screening
dc.subjectlysosomal storage diseaseseng
dc.subjectquality of lifeeng
dc.titleRecommendations for Assessment and Management of Health-Related Quality of Life in Patients with Mucopolysaccharidoses in Latin Americaeng
dc.rights.holderCopyright Latin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT)eng
dc.subject.wosGenetics & Heredityeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng, Roberto:Universidade Federal do Rio Grande do Sul, Brazil, Alejandro:Hospital de Niños Ricardo Gutiérrez, Argentina, Dafne Dain Gandelman:Fundação Oswaldo Cruz, Brazil, Edna Tiemi:Universidade Federal de São Paulo, Brazil, Ana Paula:Pontifícia Universidade Católica de Campinas, Brazil; Universidade de Campinas, BrazilÃES, Tatiana Sá Pacheco Carneiro:Biomarin Pharmaceutical Inc, Brazil, Martha Solano:Universidad Nacional de Colombia, Colombia
hcfmusp.relation.referenceAslam R, 2013, JIMD REP, V9, P59, DOI 10.1007/8904_2012_179eng
hcfmusp.relation.referenceBecker N, 1997, PAIN, V73, P393, DOI 10.1016/S0304-3959(97)00126-7eng
hcfmusp.relation.referenceBergwerk Katherine L, 2003, ScientificWorldJournal, V3, P922eng
hcfmusp.relation.referenceBrands MMG, 2015, J INHERIT METAB DIS, V38, P323, DOI 10.1007/s10545-014-9737-0eng
hcfmusp.relation.referenceBruce B, 2003, J RHEUMATOL, V30, P167eng
hcfmusp.relation.referenceBruce B, 2003, Health Qual Life Outcomes, V1eng
hcfmusp.relation.referenceChaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2eng
hcfmusp.relation.referenceCLEARY MA, 1993, ARCH DIS CHILD, V69, P403, DOI 10.1136/adc.69.3.403eng
hcfmusp.relation.referenceDoward LC, 2010, Health Qual Life Outcomes, V8eng
hcfmusp.relation.referenceDrummond M, 2014, EUR J HEALTH ECON, V15, P335, DOI 10.1007/s10198-014-0560-1eng
hcfmusp.relation.referenceESTEVEVIVES J, 1993, J RHEUMATOL, V20, P2116eng
hcfmusp.relation.referenceFRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202eng
hcfmusp.relation.referenceHarmatz P, 2013, MOL GENET METAB, V109, P54, DOI 10.1016/j.ymgme.2013.01.021eng
hcfmusp.relation.referenceHendriksz CJ, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0503-2eng
hcfmusp.relation.referenceHendriksz CJ, 2015, MOL GENET METAB, V114, P178, DOI 10.1016/j.ymgme.2014.08.012eng
hcfmusp.relation.referenceHendriksz CJ, 2013, J INHERIT METAB DIS, V36, P309, DOI 10.1007/s10545-012-9459-0eng
hcfmusp.relation.referenceHendriksz CJ, 2014, J. Inborn Errors Metab. Screen, V9eng
hcfmusp.relation.referenceHuguet A, 2008, J PAIN, V9, P226, DOI 10.1016/j.jpain.2007.10.015eng
hcfmusp.relation.referenceKato T, 2007, BRAIN DEV-JPN, V29, P298, DOI 10.1016/j.braindev.2006.08.015eng
hcfmusp.relation.referenceMachado CSM, 2001, CLIN EXP RHEUMATOL, V19, pS25eng
hcfmusp.relation.referenceMarucha J, 2012, ACTA PAEDIATR, V101, pE183, DOI 10.1111/j.1651-2227.2011.02522.xeng
hcfmusp.relation.referenceMenezes RD, 2015, QUAL LIFE RES, V24, P2761, DOI 10.1007/s11136-015-0994-7eng
hcfmusp.relation.referenceMontano AM, 2007, J INHERIT METAB DIS, V30, P165, DOI 10.1007/s10545-007-0529-7eng
hcfmusp.relation.referenceMonteiro Edilene Araújo, 2015, Rev. Bras. Enferm., V68, P421, DOI 10.1590/0034-7167.2015680307ieng
hcfmusp.relation.referenceNEUFELD EF, 1995, METABOLIC MOL BASES, P3421eng
hcfmusp.relation.referenceNoh H, 2014, J CLIN PHARM THER, V39, P215, DOI 10.1111/jcpt.12136eng
hcfmusp.relation.referenceOrlandi Aline Cristina, 2014, Sao Paulo Med. J., V132, P163, DOI 10.1590/1516-3180.2014.1323621eng
hcfmusp.relation.referencePolitei JM, 2018, J PAIN SYMPTOM MANAG, V56, P146, DOI 10.1016/j.jpainsymman.2018.03.023eng
hcfmusp.relation.referenceRaluy-Callado M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-101eng
hcfmusp.relation.referenceRavens-Sieberer U, 2010, QUAL LIFE RES, V19, P887, DOI 10.1007/s11136-010-9649-xeng
hcfmusp.relation.referenceRiazi A, 2006, Int MS J, V13, P92eng
hcfmusp.relation.referenceShapiro E, 2018, MOL GENET METAB, V123, P123, DOI 10.1016/j.ymgme.2017.11.014eng
hcfmusp.relation.referenceShapiro EG, 2017, MOL GENET METAB, V122, P8, DOI 10.1016/j.ymgme.2017.09.007eng
hcfmusp.relation.referenceSimonaro CM, 2005, PEDIATR RES, V57, P701, DOI 10.1203/01.PDR.0000156510.96253.5Aeng
hcfmusp.relation.referenceSINGH G, 1994, ARTHRITIS RHEUM, V37, P1761, DOI 10.1002/art.1780371209eng
hcfmusp.relation.referenceSomanadhan S, 2016, Orphanet J Rare Dis, V11eng
hcfmusp.relation.referenceSoni-Jaiswal A, 2016, Orphanet J Rare Dis, V11eng
hcfmusp.relation.referenceSwiedler SJ, 2005, AM J MED GENET A, V134A, P144, DOI 10.1002/ajmg.a.30579eng
hcfmusp.relation.referenceTomatsu S, 2011, CURR PHARM BIOTECHNO, V12, P931, DOI 1389-2010/11 $58.00+.00eng
hcfmusp.relation.referenceWhite K, 2010, J PEDIATR REHAB MED, V3, P57, DOI 10.3233/PRM-2010-0103eng
hcfmusp.relation.referenceWille N, 2010, QUAL LIFE RES, V19, P875, DOI 10.1007/s11136-010-9648-yeng
hcfmusp.relation.referenceWraith JE, 2004, J PEDIATR-US, V144, P581, DOI 10.1016/j.jpeds.2004.01.046eng
hcfmusp.relation.referenceThe On-Line Guide to Quality-of-Life Assessmenteng
hcfmusp.relation.referenceHealth-Related Quality of Life (HRQOL)eng
hcfmusp.relation.referenceThe Patient Reported Outcomes and Quality of Life Instrument database (PROQOLID)eng
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MPE
Departamento de Pediatria - FM/MPE

Artigos e Materiais de Revistas Científicas - LIM/36
LIM/36 - Laboratório de Pediatria Clínica

Files in This Item:
File Description SizeFormat 
art_GIUGLIANI_Recommendations_for_Assessment_and_Management_of_HealthRelated_Quality_2019.PDFpublishedVersion (English)190.82 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.